(RTTNews) - Treace Medical Concepts ... risk of nickel allergy reactions associated with traditional nitinol staples. It also supports the healing process with a unique fixation method that ...
“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...
announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation ...
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional ...
JPMorgan assumed coverage of Treace Medical (TMCI) with a Neutral rating and $8 price target While believers in the company’s Lapiplasty value proposition, the firm thinks Treace has more work ...
2025 Outlook Treace plans to provide 2025 financial guidance during its fourth quarter 2024 earnings conference call, which is currently scheduled for Thursday, February 27, 2025, at 4:30 p.m ...
PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company ...
Hosted on MSN1mon
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy RecommendationFintel reports that on December 31, 2024, Lake Street initiated coverage of Treace Medical Concepts (NasdaqGS:TMCI) with a Buy recommendation. Analyst Price Forecast Suggests 14.53% Upside As of ...
Treace, CEO, Founder and Board Member of Treace ... the potential for nickel allergy reaction associated with nitinol staples. SpeedPlate™ technology is a gamechanger for my Lapiplasty ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback